Target-specific immunoPET Imaging of Digestive System Carcinoma
Recruiting
N/A
Interventional Study
Malignancy
Digestive Cancer
Digestive System Neoplasm
Digestive System Carcinoma
Digestive System Cancer
Liver Cancer
Stomach Cancer
Colon Cancer
Rectum Cancer
Pancreatic Cancer
Esophagus Cancer
Gallbladder Carcinoma
Small Intestine Cancer
Appendix Cancer
Bile Duct Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 400 (estimated)
- Sponsor
- RenJi Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this study is to establish and optimize the target-specific PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agents in digestive system malignant tumors will be evaluated.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Aged 18-75 years old and of either sex；
2. Histologically confirmed diagnosis of digestive system carcinoma or suspected digestive system carcinoma by diagnostic imaging;
3. Capable of giving signed informed consent, including compliance with the requirements and restrictions…
Contacts